Boston Scientific Corporation (BSX)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 99.10B |
| Enterprise value | 107.73B |
| Trailing P/E | 63.01 |
| Forward P/E | 29.94 |
| PEG ratio (5-yr expected) | 1.78 |
| Price/sales (ttm) | 6.93 |
| Price/book (mrq) | 5.14 |
| Enterprise value/revenue | 7.57 |
| Enterprise value/EBITDA | 31.26 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.79 |
| 52-week change 3 | 31.91% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 69.21 |
| 52-week low 3 | 48.35 |
| 50-day moving average 3 | 67.13 |
| 200-day moving average 3 | 57.45 |
Share statistics
| Avg vol (3-month) 3 | 6.33M |
| Avg vol (10-day) 3 | 5.71M |
| Shares outstanding 5 | 1.47B |
| Implied shares outstanding 6 | 1.47B |
| Float 8 | 1.46B |
| % held by insiders 1 | 0.19% |
| % held by institutions 1 | 93.58% |
| Shares short (28 Mar 2024) 4 | 12.43M |
| Short ratio (28 Mar 2024) 4 | 2.01 |
| Short % of float (28 Mar 2024) 4 | 0.85% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.85% |
| Shares short (prior month 29 Feb 2024) 4 | 9.44M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 06 Nov 2003 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 11.18% |
| Operating margin (ttm) | 16.56% |
Management effectiveness
| Return on assets (ttm) | 4.47% |
| Return on equity (ttm) | 8.58% |
Income statement
| Revenue (ttm) | 14.24B |
| Revenue per share (ttm) | 9.80 |
| Quarterly revenue growth (yoy) | 14.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 3.61B |
| Net income avi to common (ttm) | 1.57B |
| Diluted EPS (ttm) | 1.07 |
| Quarterly earnings growth (yoy) | 260.00% |
Balance sheet
| Total cash (mrq) | 865M |
| Total cash per share (mrq) | 0.59 |
| Total debt (mrq) | 9.57B |
| Total debt/equity (mrq) | 48.99% |
| Current ratio (mrq) | 1.32 |
| Book value per share (mrq) | 13.15 |
Cash flow statement
| Operating cash flow (ttm) | 2.5B |
| Levered free cash flow (ttm) | 1.88B |
© 2024 Yahoo. All rights reserved.